CN1298313C - 用于天然结合型雌激素混合物压片的预制剂 - Google Patents

用于天然结合型雌激素混合物压片的预制剂 Download PDF

Info

Publication number
CN1298313C
CN1298313C CNB028262077A CN02826207A CN1298313C CN 1298313 C CN1298313 C CN 1298313C CN B028262077 A CNB028262077 A CN B028262077A CN 02826207 A CN02826207 A CN 02826207A CN 1298313 C CN1298313 C CN 1298313C
Authority
CN
China
Prior art keywords
weight
preformulation
pharmacopedics
hormone
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028262077A
Other languages
English (en)
Chinese (zh)
Other versions
CN1607944A (zh
Inventor
B·图姆比克
I·伯奈克尔
M·莱尔希
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals BV filed Critical Solvay Pharmaceuticals BV
Publication of CN1607944A publication Critical patent/CN1607944A/zh
Application granted granted Critical
Publication of CN1298313C publication Critical patent/CN1298313C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB028262077A 2001-12-14 2002-12-12 用于天然结合型雌激素混合物压片的预制剂 Expired - Fee Related CN1298313C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01129840.3 2001-12-14
EP01129840 2001-12-14

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNB2006101684418A Division CN100502839C (zh) 2001-12-14 2002-12-12 用于天然结合型雌激素混合物压片的预制剂

Publications (2)

Publication Number Publication Date
CN1607944A CN1607944A (zh) 2005-04-20
CN1298313C true CN1298313C (zh) 2007-02-07

Family

ID=8179550

Family Applications (2)

Application Number Title Priority Date Filing Date
CNB028262077A Expired - Fee Related CN1298313C (zh) 2001-12-14 2002-12-12 用于天然结合型雌激素混合物压片的预制剂
CNB2006101684418A Expired - Fee Related CN100502839C (zh) 2001-12-14 2002-12-12 用于天然结合型雌激素混合物压片的预制剂

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNB2006101684418A Expired - Fee Related CN100502839C (zh) 2001-12-14 2002-12-12 用于天然结合型雌激素混合物压片的预制剂

Country Status (13)

Country Link
US (2) US8273728B2 (enExample)
EP (1) EP1458363B1 (enExample)
JP (1) JP4695838B2 (enExample)
CN (2) CN1298313C (enExample)
AR (1) AR037642A1 (enExample)
AU (1) AU2002358682B2 (enExample)
BR (1) BR0214954A (enExample)
CA (1) CA2470209A1 (enExample)
ES (1) ES2403218T3 (enExample)
MX (1) MXPA04005767A (enExample)
PL (1) PL205544B1 (enExample)
TW (1) TWI332400B (enExample)
WO (1) WO2003051337A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100502839C (zh) * 2001-12-14 2009-06-24 索尔瓦药物有限公司 用于天然结合型雌激素混合物压片的预制剂

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9586335B2 (en) * 2010-01-27 2017-03-07 Sd3, Llc Blade guard with dust collection
US8349819B2 (en) 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
EP2453878A1 (en) * 2009-07-16 2012-05-23 Avantor Performance Materials, Inc. Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2589460T3 (es) * 2011-12-08 2016-11-14 Hexal Ag Nueva composición farmacéutica de estatina
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
US20210246928A1 (en) * 2020-02-11 2021-08-12 Carl Chasse Fastener having improved wobble control, fastening system including the same, and method of forming the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1036328A (zh) * 1987-12-22 1989-10-18 阿克佐公司 治疗更年期疾病和骨质疏松症的药物剂量单位
CN1197387A (zh) * 1995-07-26 1998-10-28 杜拉梅德药品有限公司 共轭雌激素药物组合物及其应用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
DE3535536A1 (de) * 1985-10-04 1987-04-09 Lentia Gmbh Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
AU722084B2 (en) 1996-08-30 2000-07-20 Abbott Products Gmbh Process to obtain oestrogens from mare's urine
AU722739B2 (en) 1996-08-30 2000-08-10 Abbott Products Gmbh Method to obtain oestrogens from mares' urine
US6200289B1 (en) 1998-04-10 2001-03-13 Milestone Scientific, Inc. Pressure/force computer controlled drug delivery system and the like
JP2000156938A (ja) 1998-11-19 2000-06-06 Hokuto Denko Kk 電池の充放電試験装置
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1036328A (zh) * 1987-12-22 1989-10-18 阿克佐公司 治疗更年期疾病和骨质疏松症的药物剂量单位
CN1197387A (zh) * 1995-07-26 1998-10-28 杜拉梅德药品有限公司 共轭雌激素药物组合物及其应用方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100502839C (zh) * 2001-12-14 2009-06-24 索尔瓦药物有限公司 用于天然结合型雌激素混合物压片的预制剂

Also Published As

Publication number Publication date
CN1977862A (zh) 2007-06-13
EP1458363A1 (de) 2004-09-22
US20120237666A1 (en) 2012-09-20
CN1607944A (zh) 2005-04-20
US20050009800A1 (en) 2005-01-13
CN100502839C (zh) 2009-06-24
PL368730A1 (en) 2005-04-04
AR037642A1 (es) 2004-11-17
US8273728B2 (en) 2012-09-25
TW200408400A (en) 2004-06-01
MXPA04005767A (es) 2004-09-10
WO2003051337A1 (de) 2003-06-26
BR0214954A (pt) 2004-12-14
JP4695838B2 (ja) 2011-06-08
US8329679B2 (en) 2012-12-11
HK1104220A1 (zh) 2008-01-11
AU2002358682A1 (en) 2003-06-30
PL205544B1 (pl) 2010-04-30
JP2005516923A (ja) 2005-06-09
CA2470209A1 (en) 2003-06-26
EP1458363B1 (de) 2013-01-16
ES2403218T3 (es) 2013-05-16
AU2002358682B2 (en) 2009-03-26
HK1075007A1 (en) 2005-12-02
TWI332400B (en) 2010-11-01

Similar Documents

Publication Publication Date Title
CN1298313C (zh) 用于天然结合型雌激素混合物压片的预制剂
CN1360499A (zh) 含有非诺贝特的药物组合物及其制备方法
CN1189171C (zh) 卡维地洛的亲水分子分散液
CN1373658A (zh) 制备遮味的且活性物质即释的包衣颗粒的方法
CN1277535C (zh) 布洛芬活性成分制剂
CN107412182B (zh) 一种盐酸二甲双胍缓释片制备方法
CN1146424C (zh) 稳定的替勃龙组合物
CN112494445A (zh) 一种马来酸氟伏沙明组合物及其制备方法
CN1174505A (zh) 含有那蒙特金的药物组合物
JP4695837B2 (ja) 複合エストロゲン天然混合物を調節して放出するマトリックス−被膜錠剤
CN1558752A (zh) 用于治疗溃疡性结肠炎和克罗恩病的含有5-氨基水杨酸的药物组合物的制备方法
CN1658868A (zh) 巴泽昔芬治疗方案
WO2014048380A1 (zh) 阿戈美拉汀固体制剂的制备方法
CN115581686A (zh) 一种普瑞巴林胶囊的制备方法和普瑞巴林胶囊
CN1812783A (zh) 具有改进释放的氟康唑胶囊
CN1371276A (zh) 低剂量片剂及其制备方法
HK1075007B (en) Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
JP2004277431A (ja) 粒状製剤及びその製造法
HK1104220B (en) Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
CN119970756A (zh) 一种含有阿法骨化醇的药物组合物及其制备方法
CN1887277A (zh) 含有降血脂成分的分散片及其制备方法
CN1774240A (zh) 含有左旋多巴和卡比多巴的药物组合物
CN119112816A (zh) 一种稳定的琥珀酸曲格列汀片及其制备工艺
CN106551908A (zh) 一种以阿戈美拉汀为活性成分的片剂
CN115590856A (zh) 一种含有利伐沙班的药物组合物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1075007

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: ABBOTT PRODUCTS, INC.

Free format text: FORMER NAME: SOLVAY PHARMACEUTICALS GMBH

CP01 Change in the name or title of a patent holder

Address after: Hannover

Patentee after: Solvay Pharm GmbH

Address before: Hannover

Patentee before: Solvay Pharmaceuticals GmbH

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070207

Termination date: 20141212

EXPY Termination of patent right or utility model